Epidemiology of Hospital-Onset Versus Community-Onset Sepsis in U.S. Hospitals and Association With Mortality: A Retrospective Analysis Using Electronic Clinical Data.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 29 5 2019
medline: 12 5 2020
entrez: 29 5 2019
Statut: ppublish

Résumé

Prior studies have reported that hospital-onset sepsis is associated with higher mortality rates than community-onset sepsis. Most studies, however, have used inconsistent case-finding methods and applied limited risk-adjustment for potential confounders. We used consistent sepsis criteria and detailed electronic clinical data to elucidate the epidemiology and mortality associated with hospital-onset sepsis. Retrospective cohort study. 136 U.S. hospitals in the Cerner HealthFacts dataset. Adults hospitalized in 2009-2015. None. We identified sepsis using Centers for Disease Control and Prevention Adult Sepsis Event criteria and estimated the risk of in-hospital death for hospital-onset sepsis versus community-onset sepsis using logistic regression models. In patients admitted without community-onset sepsis, we estimated risk of death associated with hospital-onset sepsis using Cox regression models with sepsis as a time-varying covariate. Models were adjusted for baseline characteristics and severity of illness. Among 2.2 million hospitalizations, there were 95,154 sepsis cases: 83,620 (87.9%) community-onset sepsis and 11,534 (12.1%) hospital-onset sepsis (0.5% of hospitalized cohort). Compared to community-onset sepsis, hospital-onset sepsis patients were younger (median 66 vs 68 yr) but had more comorbidities (median Elixhauser score 14 vs 11), higher Sequential Organ Failure Assessment scores (median 4 vs 3), higher ICU admission rates (61% vs 44%), longer hospital length of stay (median 19 vs 8 d), and higher in-hospital mortality (33% vs 17%) (p < 0.001 for all comparisons). On multivariate analysis, hospital-onset sepsis was associated with higher mortality versus community-onset sepsis (odds ratio, 2.1; 95% CI, 2.0-2.2) and patients admitted without sepsis (hazard ratio, 3.0; 95% CI, 2.9-3.2). Hospital-onset sepsis complicated one in 200 hospitalizations and accounted for one in eight sepsis cases, with one in three patients dying in-hospital. Hospital-onset sepsis preferentially afflicted ill patients but even after risk-adjustment, they were twice as likely to die as community-onset sepsis patients; in patients admitted without sepsis, hospital-onset sepsis tripled the risk of death. Hospital-onset sepsis is an important target for surveillance, prevention, and quality improvement initiatives.

Identifiants

pubmed: 31135503
doi: 10.1097/CCM.0000000000003817
pmc: PMC6697188
mid: NIHMS1527470
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1169-1176

Subventions

Organisme : AHRQ HHS
ID : K08 HS025008
Pays : United States
Organisme : NCEZID CDC HHS
ID : U54 CK000484
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

N Engl J Med. 2001 Nov 8;345(19):1368-77
pubmed: 11794169
Crit Care. 2004 Oct;8(5):R291-8
pubmed: 15469571
Infect Control Hosp Epidemiol. 2007 Mar;28(3):265-72
pubmed: 17326016
Infect Control Hosp Epidemiol. 2010 Jun;31(6):627-33
pubmed: 20426577
Health Serv Res. 2011 Dec;46(6pt1):1946-62
pubmed: 22092023
JAMA. 2012 Jan 11;307(2):157-64
pubmed: 22235086
Ann Intern Med. 2012 Sep 4;157(5):305-12
pubmed: 22944872
Med Care. 2014 Jun;52(6):e39-43
pubmed: 23001437
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531
Online J Public Health Inform. 2013 Jul 01;5(2):219
pubmed: 24224068
N Engl J Med. 2014 May 1;370(18):1683-93
pubmed: 24635773
N Engl J Med. 2014 Oct 16;371(16):1496-506
pubmed: 25272316
Crit Care. 2015 Apr 06;19:139
pubmed: 25887596
Crit Care Med. 2015 Aug;43(8):1669-76
pubmed: 25962082
Crit Care Med. 2015 Sep;43(9):1945-51
pubmed: 26110490
Antimicrob Resist Infect Control. 2015 Dec 29;4:57
pubmed: 26719795
Med Care. 2016 Mar;54(3):303-10
pubmed: 26759980
Ann Epidemiol. 2016 Feb;26(2):151-154.e4
pubmed: 26762962
JAMA. 2016 Apr 12;315(14):1469-79
pubmed: 26975785
Circ Heart Fail. 2016 Aug;9(8):
pubmed: 27514749
J Hosp Med. 2016 Nov;11 Suppl 1:S32-S39
pubmed: 27805796
Med Care. 2017 Jul;55(7):698-705
pubmed: 28498196
N Engl J Med. 2017 Jun 8;376(23):2235-2244
pubmed: 28528569
Ann Emerg Med. 2018 Jan;71(1):10-15.e1
pubmed: 28789803
JAMA. 2017 Oct 3;318(13):1241-1249
pubmed: 28903154
Chest. 2018 Aug;154(2):302-308
pubmed: 29804795
Infect Control Hosp Epidemiol. 2018 Aug;39(8):994-996
pubmed: 29932042
Crit Care Med. 2018 Oct;46(10):1585-1591
pubmed: 30015667
Crit Care Med. 2018 Dec;46(12):1889-1897
pubmed: 30048332
Clin Infect Dis. 2018 Nov 28;67(12):1803-1814
pubmed: 30052813
BMJ Qual Saf. 2019 Apr;28(4):305-309
pubmed: 30254095
Crit Care Med. 2019 Apr;47(4):493-500
pubmed: 30431493
JAMA Netw Open. 2019 Feb 1;2(2):e187571
pubmed: 30768188
Crit Care Med. 2019 Mar;47(3):307-314
pubmed: 30768498
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Crit Care Med. 1998 Jun;26(6):1020-4
pubmed: 9635649

Auteurs

Chanu Rhee (C)

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA.
Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Rui Wang (R)

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA.

Zilu Zhang (Z)

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA.

David Fram (D)

Commonwealth Informatics, Waltham, MA.

Sameer S Kadri (SS)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.

Michael Klompas (M)

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA.
Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH